Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform - QSAM Biosciences (OTC:QSAM)
MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (OTC:QSAM) and its